Long QT syndrome - PDFSEARCH.IO - Document Search Engine

Long QT syndrome
Results: 260

#	Item
91	Docket 04D-0377, ICH E a , linical Evaluation of QT Prolonga iat Docket 04D-0378, ICH S7B, Nonclinical Evaluation of QT Prolongation ATTACHMENT Page 14 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-12-27 14:03:22 Chemistry Biology QT interval Channelopathy Syndromes HERG Long QT syndrome Torsades de pointes Electrocardiography Cardiac dysrhythmia Cardiac electrophysiology Physiology
92	Global Regulatory Pohcy 0 Merck & Co.. Inc. Two Bethesda Metro Center Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:54 Organic chemistry Health Piperazines Channelopathy Syndromes QT interval Long QT syndrome Moxifloxacin Torsades de pointes Chemistry Cardiac dysrhythmia Cardiac electrophysiology
93	Pfizer Inc Worldwide Regulatory Affairs & Quality Assurance 50 Pequot Avenue New London, c,onnectic.yt 05320 , ,. _-_f . 1 , -_ I‘ r: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:39 Physiology QT interval Cardiac dysrhythmia Channelopathy Syndromes Long QT syndrome Piperazines Electrocardiography Methadone Chemistry Organic chemistry Cardiac electrophysiology
94	Pfizer Inc Worldwide Regulatory Affairs and Quality Assurance 50 Pequot Avenue New London, Connecticut[removed]I . Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:56 HERG Medicinal chemistry Pharmacology Biology Syndromes QT interval Long QT syndrome Cardiac dysrhythmia Health Medicine
95	Guidance for Industry S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-10-17 17:55:35 Health Cardiac electrophysiology Pharmacology Ion channels Syndromes HERG QT interval Long QT syndrome Torsades de pointes Biology Cardiac dysrhythmia Medicine
96	Microsoft Word - CCCA5AC4.doc Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:57 Health Proteins Cardiac dysrhythmia Syndromes KvLQT1 Pharmaceutical sciences Long QT syndrome HERG In vitro Ion channels Pharmacology Biology
97	ICH S7B Guideline Step 2 Revision The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-09-10 06:20:27 Medicine Cardiac dysrhythmia HERG Long QT syndrome QT interval Torsades de pointes KvLQT1 Ventricular tachycardia Cardiac action potential Biology Cardiac electrophysiology Physiology
98	November 12,2004 i ‘1 .. I Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-11-23 12:15:18 Cardiac dysrhythmia QT interval Channelopathy Syndromes Long QT syndrome Electrocardiography Qt Torsades de pointes Software Cardiac electrophysiology Physiology
99	Journal of the American College of Cardiology © 2007 by the American College of Cardiology Foundation Published by Elsevier Inc. Vol. 50, No. 14, 2007 ISSN[removed]/$32.00 Add to Reading List Source URL: www.sads.org Language: English - Date: 2010-07-30 19:42:24 Cardiac electrophysiology Biology Syndromes Channelopathy Implants Long QT syndrome Implantable cardioverter-defibrillator Ventricular tachycardia Artificial cardiac pacemaker Cardiac dysrhythmia Medicine Health
100	ABBOTT LABORATORIES Global Pharmaceutical Regulatory Affairs DouglasL. Spom Divisional Vice President Regulatory Intelligence and FDA Liaison Office Global Pharmaceutical Regulatory Affairs Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-01-05 16:25:41 Health Cardiac dysrhythmia Channelopathy Syndromes Cardiac electrophysiology QT interval Moxifloxacin Long QT syndrome Norfloxacin Chemistry Organic chemistry Piperazines